Navigation Links
Transcept Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:5/13/2009

ranscept has been working to establish a collaboration with a primary care marketing partner in the United States. In this regard, Transcept is currently engaged in discussions with potential marketing partners, but cannot predict whether such discussions will result in a collaboration, or the timing or terms under which any such collaboration would be established. If Transcept does not enter into a U.S. primary care marketing collaboration prior to the launch of Intermezzo(R), Transcept believes it would have the financial resources to carry out its plans to commercialize Intermezzo(R) on its own.

First Quarter 2009 Financial Results

Research and development expenses for the quarter ended March 31, 2009 were $2.2 million, compared to $3.6 million for the same period in 2008. The $1.4 million decrease is primarily attributable to lower Intermezzo(R) development costs, the majority of which were incurred prior to the submission of the NDA on September 30, 2008. Research and development expenses included non-cash stock compensation expense in accordance with Statement of Financial Accounting Standards No. 123R (SFAS No. 123R) of approximately $49,000 for the quarter ended March 31, 2009 and $64,000 for the quarter ended March 31, 2008.

General and administrative expenses for the quarter ended March 31, 2009 were $4.2 million, compared to $1.5 million for the same period in 2008. The $2.7 million increase consists of higher professional fees to operate as a public company, increased personnel costs primarily in marketing and administration, increased market research expenses and an increase in operational expenses associated with the addition of the Novacea office space in South San Francisco. General and administrative expenses included non-cash stock compensation expense in accordance with SFAS No. 123R of approximately $169,000 for the quarter ended March 31, 2009, as comp
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
2. Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results
3. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
4. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
5. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
6. Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel
7. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
8. Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
9. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
10. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
11. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 The report, “Specialty Synthetic ... & Geography - 2018,” defines and segments the ... an analysis and forecast of the volumes and ... (Para aramids, meta aramids, UHMW Polyethylene, carbon fiber, ... fiber, PBI fiber, PBO fiber, and liquid crystal ...
(Date:7/11/2014)... July 11, 2014 Utilizing the Keller ... Dr. William Koenig, has topped a record number of ... has performed over 400 successful procedures without the occurrence ... is well known across the country for his expertise ... record has long been the foundation for numerous studies ...
(Date:7/11/2014)... 2014 (HealthDay News) -- Children who have emergency ... complications and potentially even death than those who ... However, the Johns Hopkins researchers noted that ... researchers analyzed data on nearly 440,000 simple emergency ... over a 22-year period. The surgeries are ...
(Date:7/11/2014)... 11, 2014 The report “Probiotics ... Nutrients, Animal Feed), Applications (Regular, Therapeutic, Preventive Health ... Trends & Forecasts to 2019 ” defines and ... and forecasting of the market value of probiotic ... driving and restraining factors for the global market ...
(Date:7/11/2014)... Global enterprises today are shifting towards the ... activities. Managed services offer these global enterprises a strategic ... resulted into rising operational costs to companies. The aim ... be the global market driver for expanding the managed ... services market is estimated to grow from $142.75 billion ...
Breaking Medicine News(10 mins):Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 2Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 4Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 4
... flu has recovered from the potentially deadly illness after swift ... to the regional hospital in Pekanbaru, on Sumatra island with ... tested positive with the disease. ,"Lab results for the ... recovering quite well. She had no fever but we are ...
... have been coming to Spain's sun-kissed eastern and southern ... of the climate's restorative properties. ,But as ... foreign residents buying into the idea of retirement by ... health facilities -- to the extent that they are ...
... first to receive ready-made toilets under a state government ... But a majority of villagers were initially hesitant to ... Dabena in Bilaspur district were provided with latrines constructed ... launched in November 2005 covering five districts. But most ...
... India's leading beautician Shahnaz Hussain has tied up with ... known for private health care centres that are frequented ... for high-end clients. ,Hussain will enter into tie-up ... of Excellence on July 5. Starting Shahnaz Ayurveda on ...
... city has banned its government buildings from turning on ... (91 Fahrenheit), state media reported. ,Nanjing, capital ... set a limit on air conditioning use as pressure ... take effect over fears of power failures this summer. ...
... adjuvant treatments for breast cancer are cost-effective at improving ... 2007 issue of Cancer, a journal of the American ... of different drugs for the management of adjuvant therapies ... economic study of estrogen receptor positive breast cancers, switching ...
Cached Medicine News:Health News:Health Tourists Put Spanish Service Under Strain 2Health News:'Walk of Shame' Triggers Toilet Consciousness 2Health News:'Walk of Shame' Triggers Toilet Consciousness 3Health News:Shahnaz Hussain Takes Ayurveda to London's Harley Street 2Health News:New Adjuvant Breast Cancer Treatments Found Cost-effective 2
(Date:7/11/2014)... 2014 The consumer marketing playbook and ... sectors to better identify winning tools and techniques. ... with and understand consumers, as new technologies are ... purchasing decisions. According to recent ... area where organizations can observe a deep pool ...
(Date:7/11/2014)... Research and Markets  has announced the addition of ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... needle commonly used with a syringe to inject substances ... it. A hypodermic needle is used for rapid delivery ... ingested. Hypodermic needles are broadly classified into non-safety and ...
(Date:7/11/2014)... ALBANY, New York , July 11, 2014 /PRNewswire/ ... published by Transparency Market Research "Endoscopy Devices Market (Endoscopes, ... Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019" the ... billion in 2012 and is expected to grow at ... reach an estimated value of USD 36.9 billion in ...
Breaking Medicine Technology:New Technologies Transforming Consumer Marketing Research Playbook 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6
... N.J., Nov. 18, 2011 Kremers Urban Pharmaceuticals Inc. today ... will resolve litigation related to Lipitor® Tablets, 10 mg, 20 ... Calcium tablets.   The terms of the agreement ... by the U.S. Department of Justice and the Federal Trade ...
... Md., Nov. 18, 2011 A new report released ... that spending on medical imaging is declining and Medicare ... years.  This analysis confirms earlier findings released by the ... part of the Coalition for Patient-Centered Imaging demonstrating that ...
Cached Medicine Technology:New Analysis Shows Downward Trend in Imaging Utilization 2
... Screen Tests are available in 14 configurations ... Designed using Microgenics Antibody Technology, the SureStep ... of care immunoassay targeted to detect MDMA ... and MDEA but no cross-reactivity to any ...
AccuSign DOA Series tests include tests for Amphetamines, Barbituates, Benzodiazepines, Cocaine, Methadone, Methamphetamines, Nicotine (Cotinine), Opiates, Phencyclidine, THC, Tricyclic Antidepressan...
... The SureStep™ Drug Screen Tests are ... assay for MDMA (Ecstasy). Designed using Microgenics ... is the only point of care immunoassay ... affinity for both MDA and MDEA but ...
... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
Medicine Products: